Clinical Trials Browser

Lymphoma, Non-Hodgkin

Advanced Unresectable Solid Tumors

Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Neoplasms, Pancreatic Neoplasms

Glioblastoma

Carcinoma, Non-Small-Cell Lung

Esophageal Squamous Cell Carcinoma, Colorectal Neoplasms

Adenocarcinoma

Colonic Neoplasms, Recurrence

Precision Cell Immunotherapy

Carcinoma, Non-Small-Cell Lung

Precision Cell Immunotherapy

Precision Cells

Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Neoplasms, Stomach Neoplasms

Digestive System Neoplasms, Gastrointestinal Diseases, Intestinal Neoplasms, Neoplasms, Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Adenocarcinoma

Osteosarcoma

Breast Neoplasms

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell

Clinical Trials

F01 in the Treatment of Relapsed/Refractory Non-hodgkin's Lymphoma

Safety, Tolerability and Pharmacokinetic Profile of M108 Monoclonal Antibody in Patients With Advanced Unresectable Solid Tumors in China

A Study Comparing Immunopheresis® Alone or In Combination With Chemotherapy Versus Chemotherapy Alone in Treatment of Advanced Breast Cancer Patients

Jinfukang Oral Liquid Combined With Chemotherapy for Treating Driver Gene-negative Advanced NSCLC

Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer

EVIDENCE

A Phase III Study to Assess the Efficacy and Safety of Almonertinib Versus Platinum-based Chemotherapy as First-line Therapy in Patients With Locally Advanced or Metastatic NSCLC Harbouring Uncommon EGFR Mutation

PROTACT

Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM

Gefitinib With Chemotherapy or Anti-angiogenesis in NSCLC Patients With Bim Deletion or Low EGFR Mutation Abundance

Study of SCT-I10A Combined SCT200 or SCT-I10A Combined SCT200 Plus Chemotherapy in ESCC and CRC

Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma

CCTDRP

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer

Thymosin Alpha 1 Plus Maintenance Therapy With the Standard of Care (SoC) in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR Wild Type

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer

Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer

Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer

Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer

Icotinib in Combination With Chemotherapy Versus Chemotherapy Alone in Patients Progressed After Icotinib Treatment

Neoadjuvant Therapy of Icotinib in Epidermal Growth Factor Receptor Mutated NSCLC Patients

Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma

A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma

A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)

p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage

rAd-p53

Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia